New drugs

Fumaric acid ester now available as licensed oral psoriasis treatment

Fumaric acid ester now available as licensed oral psoriasis treatment

Prescribers treating patients with moderate to severe...

First triple combination inhaler launched for COPD

First triple combination inhaler launched for COPD

Trimbow is a 3-in-1 treatment for chronic obstructive...

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Kyntheum (brodalumab) injection is now available for...

Sufentanil: self-administered opioid for post-operative pain

Sufentanil: self-administered opioid for post-operative pain

Zalviso (sufentanil) is licensed to treat with acute...

Rolapitant: a new option for chemotherapy-induced nausea and vomiting

Rolapitant: a new option for chemotherapy-induced nausea and vomiting

Varuby (rolapitant) is a new NK1 antagonist...

New vaccination option for meningitis B

New vaccination option for meningitis B

Trumenba is now one of two meningitis B vaccines available...

New obesity treatment targets appetite and reward pathways in the brain

New obesity treatment targets appetite and reward pathways in the brain

Mysimba (naltrexone/bupropion) can be used alongside...

Eluxadoline: first treatment option for IBS patients with diarrhoea

Eluxadoline: first treatment option for IBS patients with diarrhoea

Truberzi (eluxadoline) is a new orally administered...

New antibody prevents recurrence of Clostridium difficile infection

New antibody prevents recurrence of Clostridium difficile infection

Zinplava (bezlotoxumab) is a human monoclonal antibody...

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI (salmeterol/fluticasone) is indicated...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases